Schrödinger, Inc. announced the expansion of its leadership team with the appointment of Mannix Aklian as executive vice president, chief commercial officer, global head of software sales and marketing. Mr. Aklian brings more than 25 years of experience in software sales and leadership roles within the biopharmaceutical and technology industries. Mr. Aklian will have global oversight of Schrödinger’s account management teams and will be responsible for the continued growth of the company’s software business, including the go-to-market strategy for enhancements and new products within Schrödinger’s computational platform.
“Mannix joins Schrödinger at a pivotal time as we continue to drive scale-up and adoption of our industry-leading computational platform, and he will be instrumental in building upon our strong foundation of scientific excellence and customer success,” stated Ramy Farid, Ph.D., chief executive officer of Schrödinger. “Mannix’s extensive experience in sales leadership, combined with his deep understanding of the power of computation in drug discovery make him incredibly well-suited to deliver on our software growth goals, and we look forward to his contributions to the company.”
“I am thrilled to join the talented Schrödinger team,” said Mannix Aklian. “Schrödinger’s commitment to transforming molecular discovery through computation aligns with my passion for delivering innovative solutions that can increase efficiency in the industry. I look forward to realizing the significant business opportunity Schrödinger has in both life sciences and materials science.”
Also Read: Fusion Connect Announces John Nee as Chief Marketing Officer
Mr. Aklian joins Schrödinger from Certara, where he served as senior vice president, global software sales. In this role, Mr. Aklian led a global team of professionals in sales and operations and provided executive leadership, strategic business development, and execution of software commercialization for Certara’s technology platforms. He drove sales and revenue growth globally, expanding into new market segments through strategic partnerships. Prior to Certara, Mr. Aklian was chief executive officer of LI, Inc., an enterprise software company serving the pharmaceutical industry. He led software development, commercialization and full platform operations at LI, Inc., leading the creation and deployment of multiple mobile and desktop applications. Mr. Aklian previously held sales and commercial operations roles at Molecular Devices, LLC and Corning Incorporated. He holds a B.S. in Molecular Biology and an M.S. in Molecular Biology and Biotechnology, both from Tufts University.
Source: BusinessWire
